BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38391164)

  • 21. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
    Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
    Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
    Wang M; Liao Q; Zou P
    Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1.
    Li J; He X; Wu X; Liu X; Huang Y; Gong Y
    Comput Math Methods Med; 2020; 2020():2953598. PubMed ID: 33204298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-106b-5p inhibits growth and progression of lung adenocarcinoma cells by downregulating IGSF10.
    Ling B; Liao X; Tang Q; Ye G; Bin X; Wang J; Pang Y; Qi G
    Aging (Albany NY); 2021 Jul; 13(14):18740-18756. PubMed ID: 34351868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p.
    Yang S; Liu T; Sun Y; Liang X
    Cell Mol Biol Lett; 2019; 24():70. PubMed ID: 31889958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis 
in Lung Adenocarcinoma Cells].
    Liu L; Guan X; Zhao Y; Wang X; Yin C; Liu Q; Li H
    Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):813-821. PubMed ID: 38061883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and Clinical Significance of lncRNA OSER1-AS1 in Peripheral Blood of Patients with Non-Small Cell Lung Cancer.
    Chen P; Qin Z; Sun X; Yang J; Lv J; Diao M
    Cells Tissues Organs; 2022; 211(5):589-600. PubMed ID: 34525476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma.
    Chen Y; Wu Y
    Cancer Biomark; 2023; 37(1):53-66. PubMed ID: 37005879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The miR-4732-5p/XPR1 axis suppresses the invasion, metastasis, and epithelial-mesenchymal transition of lung adenocarcinoma
    Hu Y; Bai J; Zhou D; Zhang L; Chen X; Chen L; Liu Y; Zhang B; Li H; Yin C
    Mol Omics; 2022 Jun; 18(5):417-429. PubMed ID: 35388387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
    Yin D; Zhang Y; Li H; Cheng L
    Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
    Tian WJ; Liu SS; Li BR
    Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Zhang W; Li T; Hu B; Li H
    Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
    Xu Y; Lin L; Lv D; Yan S; He S; Ge H
    Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.